Services

Counterparty Due Diligence & Trade Risk

Before you commit to an overseas buyer or supplier, understand the available evidence. Ramporrt organises company and transaction information into a practical review of what is known, what is missing and what to verify next.

When this support is useful

An unfamiliar overseas company is asking for a contract, advance payment or credit terms.

Who it fits

Importers qualifying suppliers, exporters evaluating buyers, and finance or procurement teams reviewing a proposed transaction.

Illustrative photograph of manufacturing professionals reviewing an industrial component and technical evidence together
Confidence starts with what you can verify.

Review the product, trade partner and available evidence before a commercial commitment.

What support includes

A typical deliverable

What we need to get started

Legal company name, country, website, registration details if available, proposed transaction, payment terms and the specific concern to investigate.

The engagement process

  1. Understand the requirement

    Share the product, route, decision and information already available.

  2. Agree scope and output

    Define tasks, evidence sources, provider roles, exclusions and fees.

  3. Research, review and coordinate

    Review the available evidence and follow the agreed work plan.

  4. Deliver findings and next actions

    Receive the agreed outputs, evidence gaps and practical next steps.

Scope and limits

Research-based screening is not an assurance of solvency, an exhaustive investigation or a guarantee of a safe transaction. Independent specialist verification may be needed.

Common questions

Does a clean review mean a transaction is safe?

No. It describes available evidence and its limits. Contract, payment, quality and delivery risks still require controls.

Can you review a company with limited public information?

Yes, subject to scope. Limited evidence is itself reported clearly, together with the additional documents or checks needed.

Is this a credit rating?

No. A research assessment must not be treated as a lender's credit decision or an insurer's cover approval.

Prepare for the conversation

Discuss a Counterparty Review

Tell us about the decision, product and route. We will begin by clarifying the scope.

Discuss a Counterparty Review